Human medicines European public assessment report (EPAR): Spravato, esketamine, Date of authorisation: 18/12/2019, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Spravato, esketamine, Date of authorisation: 18/12/2019, Revision: 9, Status: Authorised

Metadata
Provider: 
European Medicines AgencyEuropean Medicines Agency
URL: 
https://www.ema.europa.eu/en/medicines/human/EPAR/spravatohttps://www.ema.europa.eu/en/medicines/human/EPAR/spravato
Retrieved on: 
화요일, 1월 2, 2024
Information
Tags: 
Blood pressure, Patient, Medical Subject Headings, Marketing, DSM-IV codes, INN, Risk, Rupture, ATC, Depression, System, Bleeding, International, Headache, Nausea, Language, Brain, Dizziness, Vertigo, MADRS, Emotion, European Medicines Agency, Select, Cell, Overalls, Safety, NMDA, Anatomy, Somnolence, SSRI, IIA, SNRI, Dysgeusia, Hypoesthesia, Vomiting, Medical device
Geotags: 
EU
요약
Key Points: 


Human medicines European public assessment report (EPAR): Spravato, esketamine, Date of authorisation: 18/12/2019, Revision: 9, Status: Authorised

Copyright: 
2024 European Medicines Agency. All Rights Reserved.